menu

Quintiles Library

Show Filters
Press Release
RESEARCH TRIANGLE PARK, N.C. – June 24, 2016 – Quintiles today announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency and quality of diabetes-focused clinical trials.  When used in clinical...
Read More
Press Release
MORRISVILLE, N.C. – June 23, 2016 – Q2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts.  Each year, the Lilly...
Read More
Infographic
Quintiles helps anticipate and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience and therapeutic expertise, along with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market to transform the lives of patients and their families.
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. –  June 21, 2016 – Quintiles, the world’s largest provider of product development and integrated healthcare services, opened its global Solution Design Studio where expert teams will collaborate to create technology solutions that tackle some of healthcare’s biggest challenges.  The Studio is a highly interactive technology-driven environment...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC – June 16, 2016 – Quintiles has been named the industry leader in Phase I, Phase II/III and Phase IV services, according to the Industry Standard Research’s (ISR) 2016 CRO Quality Benchmarking — Phases I, II/III and IV reports. Quintiles also was named the best service provider across all phases of clinical development for differentiation based...
Read More
Video
Quintiles has the tremendous opportunity to conquer disease and speed medicines to patients who need them most. Learn how our team of experts transform your clinical development by helping you create better, smarter, faster trials from planning and design to post-market approval.
White Paper
医療機器メーカーは、世界全体、特にアジア太平洋地域に対しては、今後に 明るい見通しを持っています。現在の$550 億~ $600 億米ドルという市場 規模1,2 から、この地域は医療機器メーカーの販売、投資、および市場拡大 におけるホットスポットと言えます。 本書では医療機器開発と販売におけるアジア太平洋地域の魅力の背景となる 要素、ならびに同地域におけるビジネスチャンスの主導権を握るために企業 が考慮すべきことについて概説します。
Read More
Video
The field of cancer immunotherapy is developing quickly. Accordingly, there is a need for novel imaging modalities. Hear from Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, Quintiles, about immuno-PET technology and the importance of following changes in a patient’s immune system without having to take a biopsy or blood sample.
Video
Whether you need support with medical writing, developing a robust evidence generation strategy, or scaling your pivotal Phase III trial, Quintiles' solutions are tailored to meeting the needs of our emerging biopharma customers. This video takes you through the journey from early clinical to commercialization. Find out how you can benefit from personalized attention,...
Press Release
RESEARCH TRIANGLE PARK, N.C. – June 2, 2016 – Quintiles CEO Tom Pike will present at the Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 in New York City at the Grand Hyatt New York. The Quintiles presentation will begin at 10:00 a.m. (EDT).  Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 31, 2016 – Quintiles, the world’s largest provider of product development and integrated healthcare services, today announced its Precision Enrollment offering. The new enrollment model is designed to significantly accelerate site start-up and patient recruitment in oncology clinical trials working with the company’s network of...
Read More
Article
Payers, providers, patients and pharmaceutical companies all want to understand the value of specific treatments - and patient registries can help them do that. These online data platforms give patients and providers a single place to record information about diagnosis, condition and treatment experience.
Explore More
White Paper
As we enter a new era of value and outcomes-based healthcare, exercising “systems thinking” – accounting for political, economic, social and technological factors – will be critical to our collective success in improving population health. Now more than ever, industry players must team up with other healthcare stakeholders if they want to improve system performance and...
Explore More
White Paper
“The Art & Science of Evidence – Oncology” is one in a series of compendiums featuring blogs and bylined articles from Quintiles’ experts. This collection explores innovative accomplishments, new opportunities and ongoing challenges in oncology and immunotherapy research for the coming years. This future state of maximally leveraging genomic information allows for truly...
Explore More
Brochure
With the list of rare diseases across the globe expanding to nearly 7,000, it is critical to make new treatments available for these uncommon conditions. While regulatory incentives and the designation of “orphan” products have stimulated commercial research for rare diseases, their low prevalence, high complexity and  predominance in children create significant...
Read More
Presentation
Reviewing 3 years of the Post Authorization Safety Study Landscape Since the introduction of the 2010 European Pharmacovigilance legislation, a broad spectrum of public available data on Post Authorisation Safety Studies (PASS) have emerged including information on study regulatory, methodological and operational considerations. Please join us in a complimentary webinar...
Explore More
Fact Sheet
With the Quintiles Regulatory and Safety Optimization Solution, you partner with our experts to assess the value, strategy and key activities required to integrate regulatory, safety and benefit-risk management (BRM) capabilities. We analyze key data and information related to established products and current regulatory and safety operations. Our regulatory and safety...
Read More
Article
Until relatively recently, the number often quoted as the cost of bringing a new drug to market was $1 billion. In November 2014, the Tufts Center for the Study of Drug Development reported that developing new prescription medicine that gains marketing approval, a process often lasting longer than a decade, is estimated to cost $2,558 billion. Recent analysis shows that...
Explore More
Video
Where expert teams collaborate to create custom technology solutions that tackle some of healthcare's biggest challenges.
Video
At Quintiles, our employees who have nursing experience play a vital role in helping to improve patient outcomes. Five Quintiles leaders speak about how their nursing backgrounds help bring people and knowledge together for a healthier world.